Australia markets close in 20 minutes

Fortress Biotech, Inc. (FBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.8100+0.0600 (+3.43%)
At close: 04:00PM EDT
1.7700 -0.04 (-2.21%)
After hours: 07:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
77,615
84,513
75,743
68,791
45,599
Cost of revenue
32,582
26,660
30,775
32,084
14,594
Gross profit
45,033
57,853
44,968
36,707
31,005
Operating expenses
Research development
142,809
106,071
134,876
128,865
64,109
Selling general and administrative
113,155
94,124
113,656
86,843
61,166
Total operating expenses
255,295
200,195
248,532
215,708
125,275
Operating income or loss
-210,262
-142,342
-203,564
-179,001
-94,270
Interest expense
11,021
11,915
10,417
11,394
9,704
Total other income/expenses net
-284
1,021
2,344
29,307
5,229
Income before tax
-224,503
-153,633
-213,464
-164,353
-102,849
Income tax expense
521
521
449
473
136
Income from continuing operations
-224,976
-154,154
-213,913
-164,826
-102,985
Net income
-91,192
-60,637
-86,575
-64,703
-46,526
Net income available to common shareholders
-91,192
-68,669
-94,607
-64,703
-46,526
Basic EPS
-11.34
-
-15.97
-11.85
-9.75
Diluted EPS
-11.34
-
-15.97
-11.85
-9.75
Basic average shares
6,933
-
5,925
5,447
4,800
Diluted average shares
6,933
-
5,925
5,447
4,800